Naval Health Research Center, San Diego, CA 92106, USA.
Leidos, San Diego, CA 92106, USA.
Mil Med. 2022 May 3;187(5-6):149-154. doi: 10.1093/milmed/usab443.
The incidence of human papillomavirus (HPV) related cancers is growing in the United States. Active duty service members (ADSM) have higher rates of HPV infection than civilians and are therefore at greater risk of developing HPV-related cancers. The purpose of this commentary is to examine the burden of HPV-related cancers in ADSM. The current HPV vaccination and cervical cancer screening uptake rates of U.S. ADSM are presented, including a literature review of military-focused studies on HPV vaccination and cervical cancer screenings. We provide directions for future research, interventions, and policy recommendations to improve HPV-related cancer prevention among ADSM.
在美国,人乳头瘤病毒(HPV)相关癌症的发病率正在上升。现役军人(ADSM)的 HPV 感染率高于平民,因此患 HPV 相关癌症的风险更高。本评论的目的是研究 ADSM 中 HPV 相关癌症的负担。目前介绍了美国 ADSM 的 HPV 疫苗接种和宫颈癌筛查率,包括对以军队为重点的 HPV 疫苗接种和宫颈癌筛查研究的文献综述。我们为未来提高 ADSM 中 HPV 相关癌症预防的研究、干预和政策建议提供了方向。